US Patent 11116785 Antisense compounds targeting genes associated with cystic fibrosis
Patent 11116785 was granted and assigned to Rosalind Franklin University of Medicine and Science on September, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11116785 Antisense compounds targeting genes associated with cystic fibrosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
